CBLI News and Press, Cleveland BioLabs Inc. From 01/27/20

Volatility In The Market Is Good For Penny Stocks If you’re reading this penny stocks article right now, you likely saw the hit that the broader markets took over the weekend. Last week the S&P 500 declined significantly following more bad news from the spread of coronavirus into ...

Lianluo Smart (NASDAQ: LLIT ) +94% . More news on: Lianluo Smart Limited, Cleveland BioLabs, Inc., Vir Biotechnology, Inc., Stocks on the move, , Read more ...

CSS Industries (NYSE: CSS ) +99%  on being acquired by IG Design Group plc. More news on: CSS Industries, Inc., Novavax, Inc., SemiLEDs Corporation, Stocks on the move, , Read more ...

Cleveland BioLabs (NASDAQ: CBLI ): Q3 GAAP EPS of -$0.04. More news on: Cleveland BioLabs, Inc., Earnings news and commentary, Consumer stocks news, , Read more ...

BUFFALO, NY / ACCESSWIRE / November 14, 2019 / Cleveland BioLabs, Inc. (NASDAQ:CBLI) today reported financial results and development progress for the third quarter ended September 30, 2019. Cleveland BioLabs reported a net loss of $(0.4) million, excluding minority interests, for the third...

Cleveland BioLabs (CBLI) is a nano-cap company working to advance their radiation countermeasures in the military and civilian spaces in addition to other potential indications for their lead drug - entolimod. This company has been striving towards this goal for the past decade and has led inv...

Cleveland BioLabs (NASDAQ: CBLI ): Q2 GAAP EPS of -$0.05. More news on: Cleveland BioLabs, Inc., Earnings news and commentary, Consumer stocks news, , Read more ...

BUFFALO, NY / ACCESSWIRE / August 14, 2019 / Cleveland BioLabs, Inc. (NASDAQ:CBLI) today reported financial results and development progress for the second quarter ended June 30, 2019. Cleveland BioLabs reported a net loss of $(0.6) million, excluding minority interests, ...

Introduction We present here some results of a study on U.S. listed companies in the healthcare sector (Nasdaq, NYSE and Amex) based on their patent activity based on PCT (Patent Cooperation Treaty) patent applications administered by the World Intellectual Property Office (WIPO). We have sh...

Cleveland BioLabs (NASDAQ: CBLI ): Q1 GAAP EPS of -$0.08. Revenue of $0.2M (-13.0% Y/Y) Press Release More news on: Cleveland BioLabs, Inc., Earnings news and commentary, Consumer stocks news, ,